Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Tumor mechanisms of resistance to immune attack.

Zahavi DJ, Weiner LM.

Prog Mol Biol Transl Sci. 2019;164:61-100. doi: 10.1016/bs.pmbts.2019.03.009. Epub 2019 Apr 3.

PMID:
31383409
2.

Targeting Multiple Receptors to Increase Checkpoint Blockade Efficacy.

Zahavi DJ, Weiner LM.

Int J Mol Sci. 2019 Jan 4;20(1). pii: E158. doi: 10.3390/ijms20010158. Review.

3.

A Mechanism of Resistance to Antibody-Targeted Immune Attack.

Aldeghaither DS, Zahavi DJ, Murray JC, Fertig EJ, Graham GT, Zhang YW, O'Connell A, Ma J, Jablonski SA, Weiner LM.

Cancer Immunol Res. 2019 Feb;7(2):230-243. doi: 10.1158/2326-6066.CIR-18-0266. Epub 2018 Dec 18.

PMID:
30563830
4.

For staining of ALK protein, the novel D5F3 antibody demonstrates superior overall performance in terms of intensity and extent of staining in comparison to the currently used ALK1 antibody.

Taheri D, Zahavi DJ, Del Carmen Rodriguez M, Meliti A, Rezaee N, Yonescu R, Ricardo BF, Dolatkhah S, Ning Y, Bishop JA, Netto GJ, Sharma R.

Virchows Arch. 2016 Sep;469(3):345-50. doi: 10.1007/s00428-016-1969-y. Epub 2016 Jun 6.

PMID:
27271275
5.

The utility of STAT6 and ALDH1 expression in the differential diagnosis of solitary fibrous tumor versus prostate-specific stromal neoplasms.

Guner G, Bishop JA, Bezerra SM, Taheri D, Zahavi DJ, Mendoza Rodriguez MA, Sharma R, Epstein JI, Netto GJ.

Hum Pathol. 2016 Aug;54:184-8. doi: 10.1016/j.humpath.2016.03.011. Epub 2016 Apr 8.

PMID:
27068523

Supplemental Content

Loading ...
Support Center